The One Minute Cure

The One-Minute Cure reveals a remarkable, proven natural therapy that creates an environment within the body where cancer cells, viruses, bacteria, and disease microorganisms cannot thrive, thus enabling the body to CURE ITSELF of disease.

Over 91,000 research articles in the National Institutes of Health (USA) and 6,100 articles in European scientific literature have attested to the effectiveness of this safe, powerful healing modality that costs only 1-1/2 cents per day to self-administer. This 2nd Edition includes a new section showing how this one-minute protocol makes the body uninhabitable by viruses―including the coronavirus―thereby becoming “…the single most effective intervention for those battling COVID-19.”

Discover how this therapy has been administered by an estimated 15,000 European doctors, naturopaths and homeopaths to more than 10 million patients in the past 80 years to successfully treat practically every known disease — including cancer, AIDS, heart disease, diabetes, Alzheimer’s Disease, Parkinson’s Disease, hepatitis, multiple sclerosis, herpes, arthritis and asthma.

Order on Amazon: https://www.amazon.com/One-Minute-Cure-Healing-Virtually-Diseases/…

 

 

Heroes Of The Pandemic

Be Like Water

Be Like Water

“Be like water making its way through cracks. Do not be assertive, but adjust to the object, and...

FormerFedsGroup Freedom Foundation Files Amicus Curiae Brief in Support of Petitioners Lang, Fischer, and Miller in Landmark 18 U.S.C. § 1512(c)(2) Case

The FormerFedsGroup Freedom Foundation, a nonprofit primarily manned by volunteers impacted by COVID-related crimes against humanity, has filed an amicus curiae brief in a landmark legal case concerning Principal Edward Lang and co-petitioners, Joseph W. Fischer and Garrett Miller. The crux of the case revolves around the interpretation of the term “corruptly” in the federal statute 18 U.S.C. § 1512(c)(2). Thomas Renz, Esq. of Renz Law, LLC, has led this legal charge, emphasizing the ambiguous nature of the statute, which could have implications on First Amendment rights. The Foundation’s brief points to potential inconsistencies in the statute’s application and its potential misuse.

Class Action Complaint Filed Against Gilead Sciences, Inc. Over Remdesivir Alleges False Advertising And Negligence

Today, two people who suffered injuries from the drug Remdesivir (a/k/a “Veklury”), filed a class-action complaint against Gilead Sciences, Inc. for alleged violations of consumer protection laws, false advertising, deceptive promotion, negligent misrepresentation, and other charges related to the marketing and administration of the drug. The complaint seeks damages, injunctive relief, and disgorgement for personal injuries and wrongful death.

Loading